GlobalData on MSN

RevBio receives FDA clearance for cranial bone glue trial

The FDA has authorised up to 15 clinical sites to take part in the study.
Business Wire

RevBio Receives a $2.4 Million NIH Grant to Conduct a First-in-Human Clinical Trial for its Regenerative Bone Adhesive for Cranial Flap Fixation and Enrolls First Five Patients

This Clinical Trial will Show Preliminary Safety and Probable Benefit of TETRANITE ® for Replacing the Use of Metal Plates and Screws LOWELL, Mass.--(BUSINESS WIRE)--RevBio, Inc., announced that it ...
Business Wire

RevBio Receives FDA Approval to Conduct a First-in-Human Clinical Trial for its Regenerative Bone Adhesive for Cranial Flap Fixation

LOWELL, Mass.--(BUSINESS WIRE)--RevBio, Inc., announced that it has received approval from the U.S. Food and Drug Administration to start a 20-patient pilot clinical trial to examine the safety and ...